134 related articles for article (PubMed ID: 12198702)
1. The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.
Heinen CD; Goss KH; Cornelius JR; Babcock GF; Knudsen ES; Kowalik T; Groden J
Gastroenterology; 2002 Sep; 123(3):751-63. PubMed ID: 12198702
[TBL] [Abstract][Full Text] [Related]
2. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.
Hanai J; Dhanabal M; Karumanchi SA; Albanese C; Waterman M; Chan B; Ramchandran R; Pestell R; Sukhatme VP
J Biol Chem; 2002 May; 277(19):16464-9. PubMed ID: 11815623
[TBL] [Abstract][Full Text] [Related]
3. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
Versteege I; Medjkane S; Rouillard D; Delattre O
Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
6. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
7. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
[TBL] [Abstract][Full Text] [Related]
8. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
10. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.
Shivakumar L; Minna J; Sakamaki T; Pestell R; White MA
Mol Cell Biol; 2002 Jun; 22(12):4309-18. PubMed ID: 12024041
[TBL] [Abstract][Full Text] [Related]
11. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
14. The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus.
Qian J; Sarnaik AA; Bonney TM; Keirsey J; Combs KA; Steigerwald K; Acharya S; Behbehani GK; Barton MC; Lowy AM; Groden J
Gastroenterology; 2008 Jul; 135(1):152-62. PubMed ID: 18474248
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
[TBL] [Abstract][Full Text] [Related]
17. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry.
You H; Zheng H; Murray SA; Yu Q; Uchida T; Fan D; Xiao ZX
J Cell Biochem; 2002; 84(2):211-6. PubMed ID: 11787050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
